Cardiometabolic diseases are a group of metabolic dysfunctions mainly characterized by insulin resistance, impaired glucose tolerance, dyslipidemia, hypertension, and central adiposity that are major contributors to increased risk of acute vascular events such as myocardial infarction, heart failure and stroke. Cardiometabolic Diseases: Molecular Basis, Early Detection of Risks, and Management provides detailed information on all aspects of metabolic dysfunctions and associated risks for cardiometabolic diseases, including a thoughtful discussion of cellular and molecular mechanisms involved in the progression of metabolic risks, the approaches for the early detection and robust management of metabolic risks.
Written by a team of expert contributors, this book is useful reading for researchers and clinicians interested on recent advances in etiology of cardiometabolic diseases, the latest noninvasive approaches for diagnosis, risk assessment tools, therapeutic strategies, and also aspects of prevention of cardiometabolic diseases.
- Covers all aspects of cardiometabolic diseases, from cellular and molecular mechanisms involved in the development of metabolic risks to clinical practice
- Provides established guidelines that facilitate effective management of the independent risk factors that promote vascular diseases
- Discusses the use of diagnostic tools to empower patients to self-monitor the progress or regress of modifiable risks
Sprache
Verlagsort
Verlagsgruppe
Elsevier Science & Techn.
Dateigröße
ISBN-13
978-0-323-95471-6 (9780323954716)
Schweitzer Klassifikation
PrefaceForewordI. Cardiometabolic Diseases1. Cardiometabolic Diseases: Risk Factors and Novel Approaches for the Management of Risks.2. The Chennai Urban Rural Epidemiology Study (CURES) - A Compendium of type 2 diabetes in urban Asian Indians: Lessons Learnt3. Prevalence of diabetes in urban and rural India-ICMR-INDIAB study4. Burden of cardiometabolic syndrome in children.5. Diabetes care program with limited resources6. Type 2 diabetes: A Modern-Day Avatar of Malnutrition Related Diabetes7. Understanding double burden of malnutrition from a DOHaD perspective: Review of Mysore Cohorts8. Diabetes care for the bottom of the socioeconomic pyramid: Four decades of science, medicine, creativity and empathy (Samatvam India model)9. Pathophysiology of Cardiorenal Syndrome10. Evidence of Clinical Trials of Cardiac Outcomes on Renal DiseaseII. CMDs: Cellular Mechanisms11. Periodontal Disease and Occlusive Atherosclerotic Vascular Diseases12. Insulin is a cytoprotective molecule13. Galectin-3 and its associated molecular partners in the emergence and progression of cardiometabolic disorders14. Vascular Dysfunction in Obesity and Diabetes: Role of ncRNA15. In-Cardiome: Integrated knowledge base for CAD Enabling Translational Research16. Are Southeast Asians Cushingoid? A molecular explanation for the high incidence of metabolicsyndrome17. Occlusive Arterial Vascular Diseases: Cellular and Molecular Mechanisms18. Why is exercise beneficial?III. Risk Factors and Prevention19. Hypothyroidism, Diabetes and Cardiovascular disease20. Adipose Tissue and Dyslipidemia: Insight from Lipodystrophy Syndromes - why fat is not the enemy in Cardiometabolic disease21. Risk Factors for Ischemic Stroke22. Blood pressure lowering in kidney disease23. Diabetic Peripheral Vascular Disease.24. Limb salvage among people with Diabetes.25. The role of Blood Viscosity in Health and Disease26. Hypertension and Acute coronary Syndromes27. Hypertension and Stroke: An Update28. Prevention of Childhood Obesity and Diabetes : An Indian Context29. Screening of cardiovascular risk in school children and adolescents30. Diabetes Pandemic in Manitoba: An Update on Prevention of New Cases31. Type 1 diabetes risk factors and prevention32. Cardiovascular Risk Stratification in Indian Subjects: Lessons Learned and the Way Forward33. Measurement of Carotid Plaque Burden.34. Role of Metabolic State, Hemodynamics, and Neuromonitoring in Cardiac Arrest Survival and Neurological Outcome35. Secondary Stroke Prevention36. Acute Ischemic Stroke: Diagnosis and Endovascular Management37. Cardiometabolic Diseases - Recent Advance in Antithrombotic and Thrombolytic Therapies38. Management of Cardio-Metabolic Diseases: A Clinician's Perspective39. Prevention of Cardiovascular Diseases - From Science to Public Health Action
